Age-Related Macular Degeneration

The Age-Related Macular Degeneration pipeline: 43 tracked drugs, 17 approved for this indication.

17 approved / phase 412 Phase 31 Phase 2/33 Phase 23 Phase 1/21 Phase 16 preclinical / unstaged

Compare the share prices of listed companies in Age-Related Macular Degeneration →

Market size not yet sourced. How markets are sized ↗

The Age-Related Macular Degeneration pipeline

← all assets